The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.
Endogenous lipid- and peptide-derived anti-inflammatory pathways generated with glucocorticoid and aspirin treatment activate the lipoxin A4 receptor
Open accessAbstract
Aspirin (ASA) and dexamethasone (DEX) are widely used anti-inflammatory agents yet their mechanism(s) for blocking polymorphonuclear neutrophil (PMN) accumulation at sites of inflammation remains unclear. Here, we report that inhibition of PMN infiltration by ASA and DEX is a property shared by aspirin-triggered lipoxins (ATL) and the glucocorticoid-induced annexin 1 (ANXA1)-derived peptides that are both generated in vivo and act at the lipoxin A4 receptor (ALXR/FPRL1) to halt PMN diapedesis. These structurally diverse ligands specifically interact directly with recombinant human ALXR demonstrated by specific radioligand binding and function as well as immunoprecipitation of PMN receptors. In addition, the combination of both ATL and ANXA1-derived peptides limited PMN infiltration and reduced production of inflammatory mediators (that is, prostaglandins and chemokines) in vivo. Together, these results indicate functional redundancies in endogenous lipid and peptide anti-inflammatory circuits that are spatially and temporally separate, where both ATL and specific ANXA1-derived peptides act in concert at ALXR to downregulate PMN recruitment to inflammatory loci.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Inhibition of Prostaglandin Synthesis as a Mechanism of Action for Aspirin-like Drugs
VANE, J. R. (1971) · Nature New Biology · doi:10.1038/newbio231232a0 · Cited by 8,605
Acute-Phase Proteins and Other Systemic Responses to Inflammation
Gabay, C., & Kushner, I. (1999) · New England Journal of Medicine · doi:10.1056/nejm199902113400607 · Cited by 6,734
Inflammation. Basic principles and clinical correlates
(1989) · Biomedicine & Pharmacotherapy · doi:10.1016/0753-3322(89)90156-x · Cited by 2,393
A receptor for phosphatidylserine-specific clearance of apoptotic cells
Fadok, V. A., Bratton, D. L., Rose, D. M., Pearson, A., Ezekewitz, R. A. B., & Henson, P. M. (2000) · Nature · doi:10.1038/35011084 · Cited by 1,491
A G-protein-coupled receptor for leukotriene B4 that mediates chemotaxis
Yokomizo, T., Izumi, T., Chang, K., Takuwa, Y., & Shimizu, T. (1997) · Nature · doi:10.1038/42506 · Cited by 971
Arthritis and Allied Conditions: A Textbook of Rheumatology.
(1991) · Annals of Internal Medicine · doi:10.7326/0003-4819-114-9-820_6 · Cited by 766
Risk of gastrointestinal haemorrhage with long term use of aspirin: meta-analysis
Derry, S. (2000) · BMJ · doi:10.1136/bmj.321.7270.1183 · Cited by 677
Godson, C., Mitchell, S., Harvey, K., Petasis, N. A., Hogg, N., & Brady, H. R. (2000) · The Journal of Immunology · doi:10.4049/jimmunol.164.4.1663 · Cited by 638
Inflammation: Basic Principles and Clinical Correlates
Ehrlich, G. E. (2000) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.283.1.123 · Cited by 622
Su, S. B., Gong, W., Gao, J.-L., Shen, W., Murphy, P. M., Oppenheim, J. J., & Wang, J. M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.2.395 · Cited by 429
Lipocortin-1: cellular mechanisms and clinical relevance
Flower, R. J., & Rothwell, N. J. (1994) · Trends in Pharmacological Sciences · doi:10.1016/0165-6147(94)90281-x · Cited by 375
A Novel Ligand of the Formyl Peptide Receptor
Walther, A., Riehemann, K., & Gerke, V. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)80323-8 · Cited by 317
Glucocorticoids promote nonphlogistic phagocytosis of apoptotic leukocytes
Liu, Y., Cousin, J. M., Hughes, J., Van Damme, J., Seckl, J. R., Haslett, C., Dransfield, I., Savill, J., & Rossi, A. G. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.6.3639 · Cited by 299
Chiang, N., Fierro, I. M., Gronert, K., & Serhan, C. N. (2000) · The Journal of Experimental Medicine · doi:10.1084/jem.191.7.1197 · Cited by 260
Self-citationLeukotriene B4: Metabolism and Signal Transduction
Yokomizo, T., Izumi, T., & Shimizu, T. (2001) · Archives of Biochemistry and Biophysics · doi:10.1006/abbi.2000.2168 · Cited by 231
Weissmann, G. (1991) · Scientific American · doi:10.1038/scientificamerican0191-84 · Cited by 229
Mobilizing lipocortin 1 in adherent human leukocytes downregulates their transmigration
Perretti, M., Croxtall, J. D., Wheller, S. K., Goulding, N. J., Hannon, R., & Flower, R. J. (1996) · Nature Medicine · doi:10.1038/nm1196-1259 · Cited by 226
Self-citationPapayianni, A., Serhan, C. N., & Brady, H. R. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.6.2264 · Cited by 224
Self-citationClish, C. B., O’Brien, J. A., Gronert, K., Stahl, G. L., Petasis, N. A., & Serhan, C. N. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.14.8247 · Cited by 212
Self-citationLim, L. H. K., Solito, E., Russo-Marie, F., Flower, R. J., & Perretti, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.24.14535 · Cited by 167
Self-citationBrimhall, G. H. (1991) · Scientific American · doi:10.1038/scientificamerican0591-84 · Cited by 156
Becker, J. (1973) · The Lancet · doi:10.1016/s0140-6736(73)92963-2 · Cited by 154
Green, D. R., & Beere, H. M. (2000) · Nature · doi:10.1038/35011175 · Cited by 128
Samuelsson, B. O. (1983) · Bioscience Reports · doi:10.1007/bf01133779 · Cited by 127
Perretti, M., Getting, S. J., Solito, E., Murphy, P. M., & Gao, J. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64667-6 · Cited by 122
Self-citationLINKE, R. P., Bock, V., Valet, G., & Rothe, G. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)90397-p · Cited by 122
Inhibition of O2- generation by dexamethasone is mimicked by lipocortin I in alveolar macrophages.
Maridonneau‐Parini, I., Errasfa, M., & Russo-Marie, F. (1989) · Journal of Clinical Investigation · doi:10.1172/jci114101 · Cited by 106
Hench, P. S., Slocumb, C. H., Barnes, A. R., Smith, H. L., Polley, H. F., & Kendall, E. C. (1949) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(25)08438-1 · Cited by 106
Chiang, N., Takano, T., Clish, C. B., Petasis, N. A., Tai, H., & Serhan, C. N. (1998) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(24)37857-7 · Cited by 102
Self-citationNeutrophil Interaction with Inflamed Postcapillary Venule Endothelium Alters Annexin 1 Expression
Oliani, S. M., Paul‐Clark, M. J., Christian, H., Flower, R. J., & Perretti, M. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)64002-3 · Cited by 97
Self-citationCotter, M. J., Norman, K. E., Hellewell, P. G., & Ridger, V. C. (2001) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)61719-1 · Cited by 85
Aspirin: new cardiovascular uses for an old drug
Patrono, C. (2001) · The American Journal of Medicine · doi:10.1016/s0002-9343(00)00645-8 · Cited by 83
Ariel, A., Yavin, E. J., Hershkoviz, R., Avron, A., Franitza, S., Hardan, I., Cahalon, L., Fridkin, M., & Lider, O. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.5.2465 · Cited by 83
Aspirin as Prophylaxis against Colorectal Cancer
Marcus, A. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199509073331011 · Cited by 82
Arthritis and Allied Conditions: A Textbook of Rheumatology
Mckenna, C. H., & Hunder, G. G. (1973) · Arthritis & Rheumatism · doi:10.1002/art.1780160416 · Cited by 80
Les Prix Nobel : Nobel Prizes, presentations, biographies and lectures
Nobelstiftelsen (1982) · Almqvist & Wiksell International eBooks · Cited by 71
Serhan, C. N., Takano, T., Chiang, N., Gronert, K., & Clish, C. B. (2000) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/ajrccm.161.supplement_1.ltta-19 · Cited by 66
Self-citationTargets for Antiinflammatory Drugs
Cronstein, B. N., & Weissmann, G. (1995) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.002313 · Cited by 64
Acute inflammatory response in the mouse: exacerbation by immunoneutralization of lipocortin 1
Perretti, M., Ahluwalia, A., Harris, J. G., Harris, H. J., Wheller, S. K., & Flower, R. J. (1996) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.1996.tb16709.x · Cited by 60
Self-citationDEXAMETHASONE AND DEXAMETHASONE-ASPIRIN IN THE TREATMENT OF CHRONIC RHEUMATOID ARTHRITIS
Jick, H., Rs, P., Ullian, R., Slone, D., & Muench, H. (1965) · The Lancet · doi:10.1016/s0140-6736(65)90632-x · Cited by 23
Cited by
Immune regulation by glucocorticoids
Cain, D. W., & Cidlowski, J. A. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.1 · Cited by 1,846
Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators
Serhan, C. N., & Levy, B. D. (2018) · Journal of Clinical Investigation · doi:10.1172/jci97943 · Cited by 1,344
Self-citationResolution of in flammation: state of the art, definitions and terms
Serhan, C. N., Brain, S. D., Buckley, C. D., Gilroy, D. W., Haslett, C., O'Neill, L. A. J., Perretti, M., Rossi, A. G., & Wallace, J. L. (2007) · The FASEB Journal · doi:10.1096/fj.06-7227rev · Cited by 1,045
“Recent evidence has shown aspirin-triggered lipoxins and glucocorticoid-induced annexin 1 converging onto an identical receptor target, a specific 7-transmembrane spanning G-protein coupled receptor ( 27 ).”
BackgroundSelf-citationAnnexin A1 and glucocorticoids as effectors of the resolution of inflammation
Perretti, M., & D'Acquisto, F. (2009) · Nature Reviews Immunology · doi:10.1038/nri2470 · Cited by 915
Self-citationPharmacokinetics and pharmacodynamics of systemically administered glucocorticoids.
Czock, D., Keller, F., Rasche, F. M., & H??ussler, U. (2005) · Clinical Pharmacokinetics · doi:10.2165/00003088-200544010-00003 · Cited by 886
Metadata
- Authors
- Perretti, M., Chiang, N., La, M., Fierro, I. M., Marullo, S., Getting, S. J., Solito, E., & Serhan, C. N.
- Venue
- Nature Medicine
- Published
- 2002-10-07
- Volume
- 8
- Issue
- 11
- Pages
- 1296-1302
- ISSN
- 1078-8956 (ISSN-L)
- 1546-170X
- OpenAlex
- W1982283061
- Cited by
- 447
- References
- 40
- FWCI
- 18.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.